SCHEMBL72337

SCHEMBL72337

O=C(O)C(=O)P(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL1574651 0.73 BLM (0.41)
Oxalic Acid SCHEMBL1573557 0.73 BLM (0.41)
Foscarnet SCHEMBL15531347 0.73 BLM (0.41)
Foscarnet SCHEMBL8647698 0.73 BLM (0.41)
Oxalic Acid SCHEMBL7055254 0.73 BLM (0.41)
Foscarnet SCHEMBL23633 0.73
Oxalic Acid SCHEMBL25429376 0.70 BLM (0.39)
Oxalic Acid SCHEMBL5051743 0.70 BLM (0.39)
Foscarnet SCHEMBL8169999 0.70 BLM (0.39)
Foscarnet SCHEMBL5058619 0.70 BLM (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0258290-A1 METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD VORA, Shobhana (US) 1988-03-09 EP claimed
WO-1987004072-A1 METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD VORA SHOBHANA (US) 1987-07-16 WO claimed
US-11634635-B2 Polyacrylate polymers for low carbon steel corrosion control BL TECHNOLOGIES, INC. (US) 2023-04-25 US disclosed
EP-4080388-A1 MULTIMODAL, DYNAMIC, PRIVACY PRESERVING AGE AND ATTRIBUTE ESTIMATION AND LEARNING METHODS AND SYSTEMS Privately SA (CH) 2022-10-26 EP disclosed
US-20220335275-A1 MULTIMODAL, DYNAMIC, PRIVACY PRESERVING AGE AND ATTRIBUTE ESTIMATION AND LEARNING METHODS AND SYSTEMS Privately SA (CH) 2022-10-20 US disclosed
EP-2734208-A1 METHODS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS Wave Life Sciences Pte. Ltd. (SG) 2014-05-28 EP disclosed
WO-2013012758-A1 METHODS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS ONTORII, INC. (US) 2013-01-24 WO disclosed
US-8129512-B2 Using increased ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) activity as reporter function indicating regenerated photosynthetic and production processes in plants PIONEER HI-BRED INTERNATIONAL, INC. (US) 2012-03-06 US disclosed
US-20080256666-A1 METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF PIONEER HI-BRED INTERNATIONAL, INC. (US) 2008-10-16 US disclosed
EP-0449942-B1 METHOD FOR SEPARATING METAL IONS USING PHOSPHONIC ACIDS AS COMPLEXANTS ARCH DEV CORP (US) 1996-04-17 EP disclosed
US-5441983-A Herpes simplex virus, human immunodeficiency virus GENELABS INCORPORATED (US) 1995-08-15 US disclosed
CN-1100302-A Inhibition and treatment of infection by enveloped virus with calix(n)arene compounds GENELABS TECH INC (US) 1995-03-22 CN disclosed
WO-1994003164-A1 INHIBITION AND TREATMENT OF INFECTION BY ENVELOPED VIRUS WITH CALIX(N) ARENE COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 1994-02-17 WO disclosed
EP-0449942-A4 PHOSPHONIC ACIDS AND THEIR USES IN SEPARATION 1992-06-10 EP disclosed
EP-0449942-A1 PHOSPHONIC ACIDS AND THEIR USES IN SEPARATION. HORWITZ EARL PHILIP (US) 1991-10-09 EP disclosed
WO-1990005115-A1 PHOSPHONIC ACIDS AND THEIR USES IN SEPARATION HORWITZ EARL PHILIP (US) 1990-05-17 WO disclosed
EP-0258290-A1 METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD VORA, Shobhana (US) 1988-03-09 EP disclosed
WO-1987004072-A1 METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD VORA SHOBHANA (US) 1987-07-16 WO disclosed
EP-0003007-B1 ALIPHATIC DERIVATIVES OF PHOSPHONOFORMIC ACID, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COMBATING VIRUS INFECTIONS Astra Läkemedel Aktiebolag (SE) 1982-04-07 EP disclosed
EP-0003275-B1 AROMATIC DERIVATIVES OF PHOSPHONOFORMIC ACID, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR COMBATING VIRUS INFECTIONS Astra Läkemedel Aktiebolag (SE) 1981-09-02 EP disclosed